التفاصيل البيبلوغرافية
العنوان:
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
المؤلفون:
Rainer Georg Goeldner , S. Abe , Dirk Skowasch , Romain Kessler , S. Izumi , A. Barczyk , E. Belloli , J. S. Park , H. Takaya , C. Marquette , Neil Ettinger , Krishna Thavarajah , Nina Patel , Manuel Quaresma , Yasuhiko Nishioka , D Koschel , Silvia Quadrelli , M. A. Bergna , J. Sauleda , M. Salinas Fénero , J. Kang , G. Giessel , Oksana A. Shlobin , Kevin K. Brown , T. Kawamura , Ketan P. Buch , W. Randerath , O. Acosta , A. Silva Orellana , L. Wemeau , N. Sakamoto , Bruno Crestani , Sonye K. Danoff , Shane Shapera , S. Stieglitz , M. Reynaud-Gaubert , Tejaswini Kulkarni , P. Elias , Leslie Tolle , Lake Morrison , C. Glazer , Yoshikazu Inoue , Rozsa Schlenker-Herceg , Yolanda Mageto , Anand Devaraj , Zeenat Safdar , H. Hayashi , Y. Kim , Nik Hirani , Srihari Veeraraghavan , Sylvain Marchand-Adam , S. Cerri , J. Golden , D. Hotchkin , Rebecca Bascom , K. Ichikado , Martin Kolb , Nazia Chaudhuri , H. Cai , B. Crestani , J. W. Song , V. Yakusevich , Anoop M. Nambiar , Sergey Moiseev , Y. Kondoh , F. Lebargy , Wim A. Wuyts , Maria Padilla , A. Gamez-Dubuis , Sergey Avdeev , A. León Jiménez , R. Martinez , Luca Richeldi , J. Dematte D'Amico , Teng Moua , E. Bergot , J. Falk , Benjamin Bondue , K. Kishi , Danielle Antin-Ozerkis , L. Gómez Carrera , Francesco Bonella , Vincent Cottin , T. Moua , A. Villar , Stéphane Jouneau , Z. Xu , R. Hallowell , Mary E. Strek , H. Takahashi , Antje Prasse , A. Cantin , M. Okamoto , G. Criner , M. Rossman , M. Schwartz , R. Refini , Myriam Aburto , S. Makino , Y. Inoue , L. Jones , J. Burk , L. Morrow , Shelley L. Schmidt , S. Chaaban , M. Ilkovich , J. A. Rodríguez Portal , Athol U. Wells , S. Blaas , C. Andrews , D. M. Castillo Villegas , Caroline Dahlqvist , Q. Luo , H. Yamauchi , Justin M. Oldham , Julien Guiot , M. Kolb , Nitin Y. Bhatt , Y. Yamada , Maria Otaola , Alberto Pesci , E. Britt , W. Wuyts , E. Jassem , Daniel F. Dilling , Kevin R. Flaherty , H. Kitamura , H. Poonyagariyagorn , Y. Miyazaki , Robert J. Kaner , L. Pitts , Toby M. Maher , Marilyn K. Glassberg , G. Arce , J. Kus , S. Weigt , E. R. Fernández Pérez , Ivan O. Rosas , Michael Kreuter , Claudia Valenzuela , S. Tomassetti , Susanne Stowasser , K. Tomii , C. Kono , Ben Hope-Gill , D. Ziora , B. Sigal , E. Bazdyrev , R. Maturana Rozas , Paul Beirne , T. Saito , F. Varone , T. Suda , M. Arias , A. Cazaux , J. Hetzel , Helen Stone , Maria Molina-Molina , F. Riviere , L. Homik , Mary Beth Scholand , A. Gifford , W. Piotrowski , Carlo Vancheri , T. Takeuchi , H. Sugiura , M. Martínez , Hilario Nunes
المصدر:
The Lancet. Respiratory medicine, 8 (5
سنة النشر:
2020
مصطلحات موضوعية:
Diarrhea , Male , Pulmonary and Respiratory Medicine , medicine.medical_specialty , Indoles , Vital Capacity , Population , nintedanib, idiopathic pulmonary fibrosis , Settore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIO , behavioral disciplines and activities , law.invention , 03 medical and health sciences , chemistry.chemical_compound , Idiopathic pulmonary fibrosis , FEV1/FVC ratio , 0302 clinical medicine , Double-Blind Method , Randomized controlled trial , law , Internal medicine , nintedanib , medicine , Humans , 030212 general & internal medicine , education , Protein Kinase Inhibitors , Idiopathic interstitial pneumonia , Aged , education.field_of_study , business.industry , Interstitial lung disease , Nausea , Middle Aged , respiratory system , Sciences bio-médicales et agricoles , medicine.disease , Idiopathic Pulmonary Fibrosis , respiratory tract diseases , body regions , 030228 respiratory system , chemistry , Disease Progression , Female , Nintedanib , business , Hypersensitivity pneumonitis
الوصف:
The INBUILD trial investigated the efficacy and safety of nintedanib versus placebo in patients with progressive fibrosing interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF). We aimed to establish the effects of nintedanib in subgroups based on ILD diagnosis.
وصف الملف:
2 full-text file(s): application/pdf; application/pdf
اللغة:
English
URL الوصول:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12fb103566afe883ea90e5352d7b9ae8 http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/305426
حقوق:
OPEN
رقم الأكسشن:
edsair.doi.dedup.....12fb103566afe883ea90e5352d7b9ae8
قاعدة البيانات:
OpenAIRE
